Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Gepa-merz
2. L-ornithine-l-aspartate
3. Orn-asp
4. Ornithine Aspartate
5. Ornithylaspartate
1. 3230-94-2
2. L-ornithine-l-aspartate
3. L-ornithine L-aspartate Salt
4. Ornithine Aspartate
5. (s)-2,5-diaminopentanoic Acid Compound With (s)-2-aminosuccinic Acid (1:1)
6. Ornithine Aseparate
7. L-aspartic Acid, Compd. With L-ornithine (1:1)
8. (2s)-2-aminobutanedioic Acid;(2s)-2,5-diaminopentanoic Acid
9. Ornithine Aspartate (l-ornithine L-aspartate)
10. Mfcd00058084
11. Hepa-merz (tn)
12. Lola
13. Ruigan
14. Schembl361185
15. Dtxsid30883964
16. Bcp13530
17. Hy-a0282
18. Ornithine Aspartate [who-dd]
19. L-ornithine L-aspartate Salt, Powder
20. Akos015998595
21. L-ornithine-l-aspartate (salt)
22. Ornithine L-form Aspartate [mi]
23. As-12577
24. L-ornithine, L-aspartate (1:1)
25. Aspartic Acid Compd. With Ornithine
26. Cs-0019764
27. O0440
28. Ornithine, L-, L-aspartate (1:1)
29. D08303
30. D70545
31. A821231
32. Q-102756
33. Q27281401
34. (s)-2,5-diaminopentanoic Acid (s)-2-aminosuccinic Acid Salt
35. (s)-2,5-diaminopentanoicacidcompoundwith(s)-2-aminosuccinicacid(1:1)
| Molecular Weight | 265.26 g/mol |
|---|---|
| Molecular Formula | C9H19N3O6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 265.12738533 g/mol |
| Monoisotopic Mass | 265.12738533 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 228 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35044
Submission : 2020-08-19
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41004
Submission : 2024-12-23
Status : Active
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.
About the Company : Anlon Healthcare is a research-focused pharmaceutical manufacturer based in Rajkot, specializing in bulk drugs and intermediates. The company’s products comply with international...
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...

About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...

About the Company : Sailong Pharmaceutical Group Co., Ltd. ("Salon Pharmaceutical" for short) was established in 2002. It is a high-tech enterprise integrating drug research and development, productio...

About the Company : Sarshika Pharmachem LLP is a manufacturer of high-quality pharmaceutical and nutraceutical ingredients. Our mission is to offer a reliable, locally-produced alternative to Chinese-...

About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...

About the Company : Benepure is a global research, manufacture and supplier of ingredients and their derivatives for healthcare industry. It owns strong research and development team, cutting-edge equ...

About the Company : Summit ingredient Co.,Ltd is a leading and rapidly growing company wh ich engages in the production, development, source and sale of botanical extracts . Summit located in Shaanxi ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
29
PharmaCompass offers a list of L-Ornithine L-aspartate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right L-Ornithine L-aspartate manufacturer or L-Ornithine L-aspartate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Ornithine L-aspartate manufacturer or L-Ornithine L-aspartate supplier.
A L-Ornithine L-aspartate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Ornithine L-aspartate, including repackagers and relabelers. The FDA regulates L-Ornithine L-aspartate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Ornithine L-aspartate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Ornithine L-aspartate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A L-Ornithine L-aspartate supplier is an individual or a company that provides L-Ornithine L-aspartate active pharmaceutical ingredient (API) or L-Ornithine L-aspartate finished formulations upon request. The L-Ornithine L-aspartate suppliers may include L-Ornithine L-aspartate API manufacturers, exporters, distributors and traders.
click here to find a list of L-Ornithine L-aspartate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A L-Ornithine L-aspartate DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Ornithine L-aspartate active pharmaceutical ingredient (API) in detail. Different forms of L-Ornithine L-aspartate DMFs exist exist since differing nations have different regulations, such as L-Ornithine L-aspartate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Ornithine L-aspartate DMF submitted to regulatory agencies in the US is known as a USDMF. L-Ornithine L-aspartate USDMF includes data on L-Ornithine L-aspartate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Ornithine L-aspartate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Ornithine L-aspartate suppliers with USDMF on PharmaCompass.
L-Ornithine L-aspartate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Ornithine L-aspartate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right L-Ornithine L-aspartate GMP manufacturer or L-Ornithine L-aspartate GMP API supplier for your needs.
A L-Ornithine L-aspartate CoA (Certificate of Analysis) is a formal document that attests to L-Ornithine L-aspartate's compliance with L-Ornithine L-aspartate specifications and serves as a tool for batch-level quality control.
L-Ornithine L-aspartate CoA mostly includes findings from lab analyses of a specific batch. For each L-Ornithine L-aspartate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Ornithine L-aspartate may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Ornithine L-aspartate EP), L-Ornithine L-aspartate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Ornithine L-aspartate USP).